Treatment Of: Neisseria Gonorrhoeae

WHO GUIDELINES FOR THE
Treatment of
Neisseria gonorrhoeae
Web annex F: Summary of conflicts of interest
WHO Library Cataloguing-in-Publication Data
WHO guidelines for the treatment of Neisseria gonorrhoeae.

Contents: Web annex D: Evidence profiles and evidence-to-decision
framework -- Web annex E: Systematic reviews -- Web annex F: Summary
of conflicts of interest
1.Neisseria gonorrhoeae - drug therapy. 2.Gonorrhea - drug therapy.
3.Drug Resistance, Microbial. 4.Guideline. I.World Health Organization.
ISBN 978 92 4 154969 1 (NLM classification: WC 150)
© World Health Organization 2016

All rights reserved. Publications of the World Health Organization are available on the WHO website (http://www.who.int) or can be purchased from WHO
Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: bookorders@who.int).
Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution– should be addressed to WHO
Press through the WHO website (http://www.who.int/about/licensing/copyright_form/index.html). The designations employed and the presentation of the
material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status
of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps
represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’
products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not
mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have
been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed
without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event
shall the World Health Organization be liable for damages arising from its use. Printed by the WHO Document Production Services, Geneva, Switzerland
*The full guidelines and annexes are available at:

www.who.int/reproductivehealth/publications/rtis/gonorrhoea-treatment-guidelines/en/
For more information, please contact:

Department of Reproductive Health and Research
E-mail: reproductivehealth@who.int
www.who.int/reproductivehealth
Web annex F – Summary of conflicts of interest
Members of the STI Guideline Development Group (GDG)
Name Region Country Institution Declarations of conflicts of interest Meeting

(i.e. related to the topic of the meeting/guideline) restriction
Involved Declared any Declared any Declared
in related related indirectly related non-
academic commercial related commercial
work financial commercial interest or
interest financial grants
interest
Adu-Sarkodie, AFR Ghana School of Medical No No No No No
Yaw (Sax) Sciences, Kwame
Nkrumah University
of Science and
Technology
(KNUST)
Amato, Andrew EUR Sweden European Centre No No No No No
for Disease
Prevention and
Control
Bolan, Gail AMR USA Centers for Disease No No No No No
Control and
Prevention (CDC)
1
WHO guidelines for the treatment of Neisseria gonorrhoeae

interest
Changalucha, AFR United National Institute No No Yes: GSK – No No
John Republic of for Medical research
Tanzania Research, Mwanza support to
Medical Research evaluate the
Centre safety and
immunogenicity
of the GSK HPV
vaccines (ended
2011); HPV not
part of STI
guidelines
Chen, Xiang- WPR China National Center No No No No No
Sheng for STD Control,
Chinese Academy
of Medical Sciences
and Peking Union
Medical College
Chesson, Harrel AMR USA Division of STI No No No No No
Prevention, Centers
for Disease Control
and Prevention
(CDC)
Cohen, Craig AMR USA University of No No Yes: Consulted Yes: Grants not No
California, San in the related to STI
Francisco development studies
2

interest
of new drugs (National
for bacterial Institutes of
vaginosis – Health [NIH],
Symbiomix Inc. CDC and the
(US$ 8000) Bill & Melinda
Gates
Foundation)
Garcia, Francisco AMR USA Pima County Health No No No No No
Department
Garcia, Patricia AMR Peru School of Public No No No No No
Health and
Administration,
Universidad
Peruana Cayetano
Heredia
Garland, Suzanne WPR Australia Royal Women’s No No Yes: Yes: IARC – No
Hospital Merck – award support work
for HPV in HPV vaccine
(US $5,500) trials
Japan Ministry
of Health –
surveillance
of recurrent
respiratory
papillomatosis
3

interest
(US$ 50 382);
speaker at HPV
symposiums
GSK – vaccine
trial
(US$ 98 000)
CSLbio – cervical
cancer
genotypes
(US$ 210 000)
Hawkes, Sarah EUR United University College No No No No No
Kingdom London
Higgins, Mary EUR Netherlands International No No No No No
Confederation
of Midwives
Holmes, King AMR USA Department No No No No No
of Global Health
and Department
of Medicine,
University of
Washington,
Harborview
Medical Center
Klausner, Jeffrey AMR USA Division of No Yes: Standard Yes: No No (grant
4

interest
Infectious Diseases Diagnostic – Hologic, related to STI
and Program in syphilis test Cepheid, diagnostics)
Global Health, provided, Standard
David Geffen travel support Diagnostics,
School of Medicine (US$ 2000) ALere,
and Fielding School MedMira,
of Public Health, Chembio – free
University of STI tests
California, Los provided, not
Angeles related to STI
treatment
(US$ 5000)
Flora Bioscience
– candidiasis
Lewis, David AFR South Africa Western Sydney No No No No
Sexual Health
Centre, Marie
Bashir Institute for
Infectious Diseases
and Biosecurity,
Sydney Medical
School
Low, Nicola EUR Switzerland Epidemiology No No No No No
and Public Health,
University of Bern,
5

interest
Institute of Social
and Preventive
Medicine
Mabey, David EUR United London School No No No No No
Kingdom of Hygiene and
Tropical Medicine
(LSHTM)
Miranda, AMR Brazil Núcleo de Doenças No No No No No
Angelica Espinosa Infecciosas,
Universidade
Federal do Espirito
Santo
Mugo, Nelly AFR Kenya Kenya Medical No No No No No
Research Institute
Mullick, Saiqa AFR South Africa University of the No No No No No
Witwatersrand,
Hillbrow Health
Precinct
Ndowa, Francis AFR Zimbabwe Private practice No No No No No
Palefsky, Joel AMR USA Division of Yes No No No No
Infectious Diseases,
University of
California, San
Francisco
Radcliffe, Keith EUR United European STI No No No No No
Kingdom Guidelines Project,
6

interest
International Union
against Sexually
Transmitted
Infections (IUSTI),
Royal Society of
Medicine
Sabirov, Ulugbek EUR Uzbekistan National STI No No No No No
Program,
Republican Center
for Dermato-
Venereology
Schünemann, AMR Canada Department No No No No No

Holger of Clinical
Epidemiology
and Biostatistics,
McMaster
University
Steen, Richard EUR Italy Erasmus University No No No No No
Stephenson, EUR United University College No No No No No
Judith Kingdom London
Unemo, Magnus EUR Sweden Department of No No No No No
Laboratory
Medicine,
Microbiology,
Örebro University
7

interest
Hospital
Vuylsteke, Bea EUR Belgium Institute of Tropical No No No No No
Medicine
Wald, Anna AMR USA University of No No Yes: Involved No No
Washington, in the
Virology Research development of
Clinic, Harborview herpes simplex
Medical Center virus (HSV)
vaccination
Wasserheit, AMR USA Department of No No No No No
Judith Global Health
and Medicine,
University of
Washington
Wong, Thomas AMR Canada Division of No No No No No
Community
Acquired
Infections, Centre
for Communicable
Diseases and
Infection Control,
Public Health
Agency of Canada
Workowski, AMR USA Centers for No No No No No
Kimberly A. Disease Control
and Prevention,
8

interest
Division of
Infectious
Diseases, Emory
University School
of Medicine
WHO regions:
AFR: African Region; AMR: Region of the Americas; EMR: Eastern Mediterranean Region; EUR: European Region; SEAR: South-East Asian Region; WPR: Western Pacific Region
9
Methodologist

(please indicate “yes” or “no” for each section) restriction
interest
Santesso, Nancy AMR Canada Department No No No No No

of Clinical
Epidemiology
and Biostatistics,
McMaster
University
AMR: Region of the Americas
10
Members of the External Review Group

in related related indirectly related related non-
academic commercial commercial commercial
work financial financial interest interest or
interest grants
Abu-Raddad, EMR Qatar Department of No No No No No
Laith Public Health, Weill
Cornell Medical
College, Cornell
University, Qatar
Foundation –
Education City
Akolo, Chris AMR USA FHI 360 No No No No No
Bala, Manju SEAR India WHO Gonorrhoea No No No No No
Antimicrobial
Surveillance
Programme (GASP)
South-East Asia
Regional Reference
Laboratory,
Vardhman Mahavir
Medical College
(VMMC) and
Safdarjang Hospital
Betie, Mircea EUR Republic of Nicolae No No No No No
Moldova Testemițanu State
University of
Medicine and
Pharmacy
11

interest grants
Deal, Carolyn AMR USA National Institute No No No No No
of Allergy and
Infectious Diseases
(NIAID), United
States Department
of Health and
Human Services,
National Institutes
of Health
Dillon, Jo-Anne R. AMR Canada College of Arts and No No No No No

Science, University
of Saskatchewan
Gale-Row, AMR Canada Professional No No No No No

Margaret Guidelines and
Public Health
Practice Division,
Centre for
Communicable
Diseases and
Infection Control,
Public Health
Agency of Canada
12

interest grants
Geisler, William AMR USA University of No Yes: No No No
M. Alabama at Activbiotics
Birmingham Pharma, LLC –
involved in
protocol
development of
phase 2 clinical
trial of rifalazil
for chlamydia
treatment
(US$ 4987)
Warner Chilcott
LLC – review
efficacy data
for clinical trial
of a chlamydia
drug – FDA
discussion
(US$ 10 640)
Kettani, Amina El EMR Morocco Direction de No No No No No

l’Epidemiologie,
Service des MST-
sida, Ministry
of Health
13

interest grants
Lahra, Monica WPR Australia Division of No No No No No
Bacteriology,
WHO Collaborating
Centre for STD and
Neisseria Reference
Laboratory,
Department of
Microbiology, The
Prince of Wales
Hospital,
New South Wales
Kiros, Mizan AFR Ethiopia Disease Prevention No No No No No
and Control
Directorate
Federal Ministry
of Health
Latif, Ahmed AFR Zimbabwe Public Health No No No No No
Consultant
Mayaud, Philippe EUR United Clinical Research No No No No No
Kingdom Department,
Faculty of
Infectious and
Tropical Diseases,
London School
of Hygiene and
Tropical Medicine
14

interest grants
McCartney, David EUR United Research and No No No No No
Kingdom Technical Support,
International
Planned
Parenthood
Federation
Mir, Ali M. EMR Pakistan Population Council No No No No No
Ortayli, Nuriya EMR Turkey United Nations No No No No No
Population Fund
(UNFPA)
Singh, Aman SEAR India National AIDS No No No No No
Kumar Control
Organization,
Ministry of Health
and Family Welfare
Sirivongrangson, SEAR Thailand Department of No No No No No
Pachara Diseases Control,
Bureau of AIDS, TB
and STIs, Ministry
of Public Health
AFR: African Region; AMR: Region of the Americas; EMR: Eastern Mediterranean Region; EUR: European Region; SEAR: South-East Asian Region; WPR:
Western Pacific Region
15

Treatment Of: Neisseria Gonorrhoeae

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Treatment Of: Neisseria Gonorrhoeae

Uploaded by

Copyright:

Available Formats

WHO GUIDELINES FOR THE

WHO guidelines for the treatment of Neisseria gonorrhoeae.

© World Health Organization 2016

*The full guidelines and annexes are available at:

For more information, please contact:

Members of the STI Guideline Development Group (GDG)

Name Region Country Institution Declarations of conflicts of interest Meeting

Name Region Country Institution Declarations of conflicts of interest Meeting

Name Region Country Institution Declarations of conflicts of interest Meeting

Name Region Country Institution Declarations of conflicts of interest Meeting

Name Region Country Institution Declarations of conflicts of interest Meeting

Name Region Country Institution Declarations of conflicts of interest Meeting

Name Region Country Institution Declarations of conflicts of interest Meeting

Schünemann, AMR Canada Department No No No No No

Name Region Country Institution Declarations of conflicts of interest Meeting

Name Region Country Institution Declarations of conflicts of interest Meeting

Name Region Country Institution Declarations of conflicts of interest Meeting

Santesso, Nancy AMR Canada Department No No No No No

AMR: Region of the Americas

Members of the External Review Group

Name Region Country Institution Declarations of conflicts of interest Meeting

Name Region Country Institution Declarations of conflicts of interest Meeting

Dillon, Jo-Anne R. AMR Canada College of Arts and No No No No No

Gale-Row, AMR Canada Professional No No No No No

Name Region Country Institution Declarations of conflicts of interest Meeting

Kettani, Amina El EMR Morocco Direction de No No No No No

Name Region Country Institution Declarations of conflicts of interest Meeting

Name Region Country Institution Declarations of conflicts of interest Meeting

You might also like